Velan Capital Investment Management
Latest statistics and disclosures from Velan Capital Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALIM, Praxis Precision Medicines I, HRTX, Jasper Therapeutics, ADMA, and represent 57.84% of Velan Capital Investment Management's stock portfolio.
- Added to shares of these 9 stocks: ALIM (+$37M), INSP, HRTX, GOSS, APLS, ASLN, QIPT, CGEM, IOVA.
- Started 4 new stock positions in GOSS, INSP, APLS, ASLN.
- Reduced shares in these 10 stocks: ADMA, GRTX, Point Biopharma Global, CTLT, ETNB, THC, LNTH, AVDL, CABA, AIRS.
- Sold out of its positions in AIRS, AVDL, CTLT, ETNB, GRTX, Point Biopharma Global.
- Velan Capital Investment Management was a net buyer of stock by $28M.
- Velan Capital Investment Management has $123M in assets under management (AUM), dropping by 13.84%.
- Central Index Key (CIK): 0001848809
Tip: Access up to 7 years of quarterly data
Positions held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 28 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Alimera Sciences Com New (ALIM) | 34.2 | $42M | +719% | 14M | 3.10 |
|
| Praxis Precision Medicines I | 7.2 | $8.9M | 5.2M | 1.71 |
|
|
| Heron Therapeutics (HRTX) | 5.8 | $7.2M | +55% | 7.0M | 1.03 |
|
| Jasper Therapeutics | 5.5 | $6.8M | 11M | 0.61 |
|
|
| Adma Biologics (ADMA) | 5.0 | $6.2M | -36% | 1.7M | 3.58 |
|
| Quipt Home Medical Corporation Call Option (QIPT) | 5.0 | $6.1M | +12% | 1.2M | 5.09 |
|
| Tela Bio (TELA) | 4.8 | $6.0M | 746k | 8.00 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 4.2 | $5.2M | -25% | 75k | 69.48 |
|
| Optinose (OPTN) | 3.6 | $4.4M | 3.6M | 1.23 |
|
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.6 | $3.2M | 55k | 57.00 |
|
|
| Inspire Med Sys (INSP) | 2.5 | $3.0M | NEW | 15k | 198.44 |
|
| ImmunoGen | 2.4 | $3.0M | 190k | 15.87 |
|
|
| Inspiremd (NSPR) | 2.4 | $3.0M | 904k | 3.27 |
|
|
| Gossamer Bio (GOSS) | 2.1 | $2.6M | NEW | 3.1M | 0.83 |
|
| Cabaletta Bio (CABA) | 1.9 | $2.3M | -40% | 150k | 15.22 |
|
| Apellis Pharmaceuticals (APLS) | 1.5 | $1.9M | NEW | 50k | 38.04 |
|
| Geron Corporation (GERN) | 1.3 | $1.7M | 779k | 2.12 |
|
|
| Tenet Healthcare Corp Com New (THC) | 1.3 | $1.6M | -51% | 25k | 65.89 |
|
| Icosavax | 1.0 | $1.2M | 161k | 7.75 |
|
|
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 1.0 | $1.2M | NEW | 625k | 1.88 |
|
| Iovance Biotherapeutics Call Option (IOVA) | 0.9 | $1.1M | +4% | 250k | 4.55 |
|
| Annexon (ANNX) | 0.9 | $1.1M | 460k | 2.36 |
|
|
| Edesa Biotech | 0.7 | $810k | 1.3M | 0.63 |
|
|
| Cullinan Oncology (CGEM) | 0.6 | $679k | +50% | 75k | 9.05 |
|
| Inflarx Nv (IFRX) | 0.5 | $596k | 200k | 2.98 |
|
|
| Rezolute Com New (RZLT) | 0.4 | $528k | 400k | 1.32 |
|
|
| Inhibrx (INBX) | 0.4 | $459k | 25k | 18.35 |
|
|
| Elevation Oncology (ELEV) | 0.3 | $330k | 497k | 0.66 |
|
Past Filings by Velan Capital Investment Management
SEC 13F filings are viewable for Velan Capital Investment Management going back to 2021
- Velan Capital Investment Management 2023 Q3 filed Nov. 13, 2023
- Velan Capital Investment Management 2023 Q2 filed Aug. 11, 2023
- Velan Capital Investment Management 2023 Q1 filed May 15, 2023
- Velan Capital Investment Management 2022 Q4 filed Feb. 13, 2023
- Velan Capital Investment Management 2022 Q3 filed Nov. 14, 2022
- Velan Capital Investment Management 2022 Q2 filed Aug. 15, 2022
- Velan Capital Investment Management 2022 Q1 filed May 16, 2022
- Velan Capital Investment Management 2021 Q4 filed Feb. 14, 2022